Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « AffRegInc.i » - entrée « Florence »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Firenze 50139 < Florence < Florence  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 14.
Ident.Authors (with country if any)Title
000164 (2020) Maurizio Benucci [Italie] ; Luciana Tramacere [Italie] ; Maria Infantino [Italie] ; Mariangela Manfredi [Italie] ; Valentina Grossi [Italie] ; Arianna Damiani [Italie] ; Francesca Li Gobbi [Italie] ; Maristella Piccininni [Italie] ; Gaetano Zaccara [Italie] ; Massimo Cincotta [Italie]Efficacy of Tocilizumab in Limbic Encephalitis with Anti-CASPR2 Antibodies.
000335 (2019) Laura Bazzichi [Italie] ; Francesca Nacci [Italie] ; Luigi Sinigaglia [Italie] ; Laura Bianchino [Italie] ; Roberto Caporali [Italie]Subcutaneous tocilizumab alone or with a csDMARD in rheumatoid arthritis patients: subanalysis of Italian data from a multicenter phase IIIb/IV trial.
000643 (2018) Gianfranco Vitiello [Italie] ; Carolina Orsi Battaglini [Italie] ; Giulia Carli [Italie] ; Anna Radice [Italie] ; Andrea Matucci [Italie] ; Alessandra Vultaggio [Italie] ; Catia Olianti [Italie] ; Paola Parronchi [Italie] ; Enrico Maggi [Italie] ; Daniele Cammelli [Italie]Tocilizumab in Giant Cell Arteritis: A Real-Life Retrospective Study.
000872 (2018) Ciriana Orabona [Italie] ; Giada Mondanelli [Italie] ; Maria T. Pallotta [Italie] ; Agostinho Carvalho [Portugal] ; Elisa Albini [Italie] ; Francesca Fallarino [Italie] ; Carmine Vacca [Italie] ; Claudia Volpi [Italie] ; Maria L. Belladonna [Italie] ; Maria G. Berioli [Italie] ; Giulia Ceccarini [Italie] ; Susanna Mr Esposito [Italie] ; Raffaella Scattoni [Italie] ; Alberto Verrotti [Italie] ; Alessandra Ferretti [Italie] ; Giovanni De Giorgi [Italie] ; Sonia Toni [Italie] ; Marco Cappa [Italie] ; Maria C. Matteoli [Italie] ; Roberta Bianchi [Italie] ; Davide Matino [Italie] ; Alberta Iacono [Italie] ; Matteo Puccetti [Italie] ; Cristina Cunha [Portugal] ; Silvio Bicciato [Italie] ; Cinzia Antognelli [Italie] ; Vincenzo N. Talesa [Italie] ; Lucienne Chatenoud [France] ; Dietmar Fuchs [Autriche] ; Luc Pilotte ; Benoît Van Den Eynde ; Manuel C. Lemos [Portugal] ; Luigina Romani [Italie] ; Paolo Puccetti [Italie] ; Ursula Grohmann [Italie]Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1in juvenile diabetes.
000903 (2018) Rossella Talotta [Italie] ; Fabiola Atzeni [Italie] ; Alberto Batticciotto [Italie] ; Maurizio Benucci [Italie] ; Sara Bongiovanni [Italie] ; Piercarlo Sarzi-Puttini [Italie]Biological Agents in Rheumatoid Arthritis: A Cross-Link Between Immune Tolerance and Immune Surveillance.
000A66 (2017) Fabrizio Cantini [Italie] ; Laura Niccoli [Italie] ; Carlotta Nannini [Italie] ; Emanuele Cassarà [Italie] ; Olga Kaloudi [Italie] ; Ennio Giulio Favalli [Italie] ; Andrea Becciolini [Italie] ; Maurizio Benucci [Italie] ; Francesca Li Gobbi [Italie] ; Serena Guiducci [Italie] ; Rosario Foti [Italie] ; Marta Mosca [Italie] ; Delia Goletti [Italie]Second-line biologic therapy optimization in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
000B53 (2017) Achille Marino [Italie] ; Sona Narula [États-Unis] ; Melissa A. Lerman [États-Unis]First Pediatric Patient With Neuromyelitis Optica and Sjögren Syndrome Successfully Treated With Tocilizumab.
000C89 (2016) Gianfranco Vitiello [Italie] ; Boaz Palterer [Italie] ; Paola Parronchi [Italie] ; Daniele Cammelli [Italie]Tocilizumab-induced mucosal ulcers in a patient with relapsing polychondritis: An adverse drug reaction?
000C90 (2016) Giacomo Emmi [Italie] ; Elena Silvestri [Italie] ; Danilo Squatrito [Italie] ; Lorenzo Emmi [Italie] ; Luca Cantarini [Italie] ; Domenico Prisco [Italie]Tocilizumab-induced exacerbation of mucosal ulcers in a patient with multi-refractory Behçet׳s disease.
000D28 (2016) Fabrizio Cantini [Italie] ; Laura Niccoli [Italie] ; Carlotta Nannini [Italie] ; Emanuele Cassarà [Italie] ; Olga Kaloudi [Italie] ; Ennio Giulio Favalli [Italie] ; Andrea Becciolini [Italie] ; Martina Biggioggero [Italie] ; Maurizio Benucci [Italie] ; Francesca Li Gobbi [Italie] ; Valentina Grossi ; Maria Infantino ; Francesca Meacci ; Mariangela Manfredi ; Serena Guiducci [Italie] ; Silvia Bellando-Randone [Italie] ; Marco Matucci-Cerinic [Italie] ; Rosario Foti [Italie] ; Marcella Di Gangi [Italie] ; Marta Mosca [Italie] ; Chiara Tani [Italie] ; Fabrizio Palmieri [Italie] ; Delia Goletti [Italie]Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis.
000E90 (2016) Maurizio Benucci [Italie] ; Francesca Meacci [Italie] ; Valentina Grossi [Italie] ; Maria Infantino [Italie] ; Mariangela Manfredi [Italie] ; Emanuele Bellio [Italie] ; Valerio Bellio [Italie] ; Francesca Li Gobbi [Italie] ; Laura Bazzichi [Italie] ; Paolo Moscato [Italie] ; Dario Caputo [Italie] ; Gianantonio Saviola [Italie] ; Rossella Talotta [Italie] ; Piercarlo Sarzi-Puttini [Italie] ; Fabiola Atzeni [Italie]Correlations between immunogenicity, drug levels, and disease activity in an Italian cohort of rheumatoid arthritis patients treated with tocilizumab.
001140 (2015) Diego Sangiorgi [Italie] ; Maurizio Benucci [Italie] ; Carmela Nappi [Italie] ; Valentina Perrone [Italie] ; Stefano Buda [Italie] ; Luca Degli Esposti [Italie]Drug usage analysis and health care resources consumption in naïve patients with rheumatoid arthritis.
001C52 (????) Antonella Fioravanti [Italie] ; Sara Tenti [Italie] ; Maria Romana Bacarelli [Italie] ; Arianna Damiani [Italie] ; Francesca Li Gobbi [Italie] ; Francesca Bandinelli [Italie] ; Sara Cheleschi [Italie] ; Mauro Galeazzi [Italie] ; Maurizio Benucci [Italie]Tocilizumab modulates serum levels of adiponectin and chemerin in patients with rheumatoid arthritis: potential cardiovascular protective role of IL-6 inhibition.
001C66 (????) Sergio Iannazzo [Italie] ; Maurizio Benucci [Italie] ; Ennio Giulio Favalli [Italie]Tocilizumab after a first-line with anti-TNF in rheumatoid arthritis: a cost-consequence analysis in the Italian setting.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/AffRegInc.i -k "Florence" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/AffRegInc.i  \
                -Sk "Florence" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    AffRegInc.i
   |clé=    Florence
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021